These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16670463)

  • 41. Podoplanin is a potential marker for the diagnosis of ependymoma: a comparative study with epithelial membrane antigen (EMA).
    Ishizawa K; Komori T; Shimada S; Hirose T
    Clin Neuropathol; 2009; 28(5):373-8. PubMed ID: 19788053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431.
    Atsumi N; Ishii G; Kojima M; Sanada M; Fujii S; Ochiai A
    Biochem Biophys Res Commun; 2008 Aug; 373(1):36-41. PubMed ID: 18539139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma.
    Nakayama Y; Matsumoto K; Nagato M; Inoue Y; Katsuki T; Minagawa N; Shibao K; Tsurudome Y; Hirata K; Higure A; Sako T; Nagata N
    Anticancer Res; 2007; 27(1B):619-25. PubMed ID: 17348451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas.
    Saqi A; Yun SS; Yu GH; Alexis D; Taub RN; Powell CA; Borczuk AC
    Diagn Cytopathol; 2005 Aug; 33(2):65-70. PubMed ID: 16007640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
    Parsons A; Sheehan DJ; Sangueza OP
    Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
    Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of expression of podoplanin by microvenular hemangioma.
    Fernandez-Flores A
    Pathol Res Pract; 2008; 204(11):817-21. PubMed ID: 18650031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D2-40-positive solitary fibrous tumors of the pleura: diagnostic pitfall of biopsy specimen.
    Naito Y; Ishii G; Kawai O; Hasebe T; Nishiwaki Y; Nagai K; Ochiai A
    Pathol Int; 2007 Sep; 57(9):618-21. PubMed ID: 17685935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?
    Deniz H; Kibar Y; Güldür ME; Bakir K
    Pathol Res Pract; 2009; 205(11):749-52. PubMed ID: 19573998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
    Kandil DH; Cooper K
    Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures.
    Tsuneki M; Maruyama S; Yamazaki M; Cheng J; Saku T
    Pathol Res Pract; 2012 Mar; 208(3):140-6. PubMed ID: 22326634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphatic differentiation in renal angiomyolipomas.
    Bonsib SM; Moghadamfalahi M; Bhalodia A
    Hum Pathol; 2009 Mar; 40(3):374-80. PubMed ID: 18973924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas.
    Mankey CC; McHugh JB; Thomas DG; Lucas DR
    Histopathology; 2010 Feb; 56(3):364-71. PubMed ID: 20459536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical expression of osteopontin in epithelioid mesotheliomas and reactive mesothelial proliferations.
    Tigrani DY; Weydert JA
    Am J Clin Pathol; 2007 Apr; 127(4):580-4. PubMed ID: 17369133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.
    Amatya VJ; Takeshima Y; Kohno H; Kushitani K; Yamada T; Morimoto C; Inai K
    Histopathology; 2009 Jul; 55(1):10-9. PubMed ID: 19614762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extrathoracic mesothelial proliferations and their mimics.
    Lloreta-Trull J
    Ultrastruct Pathol; 2006; 30(1):37-51. PubMed ID: 16517469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
    Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
    J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re: Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
    Tutar E
    Pathol Int; 2009 Apr; 59(4):274; author reply 274. PubMed ID: 19351375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.